Download
Download by
Scanning QR Code
No matches yet
Please check network settings and try again Refresh
Loading
Futu Hot Stocks
    Latest News
    History record delete
      Quotes All >
      News All >
      Help All >

      • Download app

        Download app

      +
      Congratulations
      You've successfully got advanced quotes worth 5000 HKD
      Download APP >>
      Quotes
      Detailed Quotes
      Company Overview
      Company ProfileCompany Executives
      Financial Analysis
      Main CompositionKey IndicatorsFinancial Statement
      Multi-dimentional Analyses
      Company Valuation Capital Tracking Short Selling Data
      Futubull > Quotes > TCBP TC BioPharm > Financial Statement > Income statement
      TCBP TC BioPharm
      0.7100.0000.00%
      Post Mkt Price
      0.691
      -0.019-2.65%
      Income statement Balance sheet Cash flow
      YOY
      Do not show
      Hide blank lines
      (FY)2022/12/31(FY)2021/12/31(Q4)2021/12/31(Q3)2021/09/30
      Total revenue
      94.30% 3.84M 0.00% 1.98M 0.00% 494.67K 494.66K
      Operating revenue
      94.30% 3.84M 0.00% 1.98M 0.00% 494.67K -- 494.66K
      Cost of revenue
      Gross profit
      Operating expense
      70.27% 15.77M 11.32% 9.26M 33.78% 2.82M 2.65M
      Selling and administrative expenses
      167.57% 8.32M 40.88% 3.11M 111.76% 1.18M -- 1.05M
      -General and administrative expense
      167.57% 8.32M 40.88% 3.11M 111.76% 1.18M -- 1.05M
      Research and development costs
      20.96% 7.45M -7.83% 6.16M 4.99% 1.65M -- 1.6M
      Other operating expenses
      -- -- 98.88% -6.38K 96.83% -435 -- 0
      Operating profit
      -63.74% -11.92M -14.86% -7.28M -44.12% -2.33M -2.16M
      Net non-operating interest income expense
      -103.35% -6.99M -1,081.49% -3.44M -2,692.96% -1.92M -1.15M
      Non-operating interest income
      6,590.91% 2.21K -96.79% 33 -98.78% 5 -- 7
      Non-operating interest expense
      103.41% 6.99M 1,077.33% 3.44M 2,676.43% 1.92M -- 1.15M
      Other net income (expense)
      470.60% 15.8M -4.26M -271.35K
      Gain on sale of security
      473.89% 15.94M -- -4.26M -- -271.35K -- --
      Other non- operating income (expenses)
      -- -140.34K -- -- -- -- -- --
      Income before tax
      79.25% -3.11M -126.00% -14.98M -168.52% -4.52M -7.3M
      Income tax
      -22.20% -1.72M -20.10% -1.41M -71.04% -620.09K -274.94K
      Net income
      89.76% -1.39M -148.74% -13.58M -195.27% -3.9M -7.03M
      Net income continuous Operations
      89.76% -1.39M -148.74% -13.58M -195.27% -3.9M -- -7.03M
      Minority interest income
      Net income attributable to the parent company
      89.76% -1.39M -148.74% -13.58M -195.27% -3.9M -7.03M
      Preferred stock dividends
      Other preferred stock dividends
      Net income attributable to common stockholders
      89.76% -1.39M -148.74% -13.58M -195.27% -3.9M -7.03M
      Basic earnings per share
      94.18% -2.02 -257.04% -34.7253 -323.83% -9.976 -17.9756
      Diluted earnings per share
      94.18% -2.02 -257.04% -34.7253 -323.83% -9.976 -17.9756
      Dividend per share
      Currency Unit
      GBPGBPGBPGBP
      Audit Opinions
      Unqualified Opinion with Explanatory NotesUnqualified Opinion with Explanatory Notes----

      FY: Financial Year Annual Report, which is equivalent to the 10-K file disclosed by the listed company to the SEC.

      Q: Quarterly report, which is equivalent to the 10-Q file disclosed by the listed company to the SEC, where Q1, Q2, Q3, and Q4 are single quarterly reports with a span of 3 months; Q6 and Q9 are cumulative quarterly reports, and Q6 is 6 months , Q9 is 9 months.

      The MOM data from the Quarterly report，MOM=(current period - last period)/last period *100%

      Company Overview More
      CEO： Mr. Bryan Kobel
      Market： NASDAQ
      Listing Date： 02/11/2022
      Futu Hot List
      USHKCN
      TradeSearchNews
      SymbolLatest price%Chg

      Loading...

      Watchlist
      Back to the Top